AM/AMBP-1 shortened angiogenesis phase during wound closure.

<p><b>A</b>. Skin tissues from Vehicle (<b>a, b</b>) and AM/AMBP-1 (<b>c, d</b>) treated animals from day 3 (<b>a, c</b>) and day 14 (<b>b, d</b>) were sectioned and immunostained with CD31 antibody. <b>B</b>. Skin tissues from Vehicle (<b>a</b>) and AM/AMBP-1 (<b>b</b>) treated animals from day 14 were sectioned and immunostained with α-SMA antibody. Total RNA extracted from skin tissues were analyzed by real time RT-PCR for VEGF (<b>C</b>) and TGFβ-1 (<b>D</b>) mRNA expressions. Data are represented as mean ± SEM (n = 4–5/group) and compared by Student’s <i>t</i>-test. *P<0.05 vs. Vehicle.